About Shape Therapeutics. ShapeTX is an AI-driven genomic medicines company focused on creating curative and transformative medicines through its programmable RNA editing technology.

Shape Therapeutics. By Rick Morgan – Inno Senior Reporter, Puget Sound Business Journal. May 6, 2025. Updated May 7, 2025 12:29pm PDT. Preview this article 1 min.

SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the ...

Recent developments in U.S. domestic affairs include a legal victory for Anthropic in an AI training lawsuit, Treasury ...

The first manuscript, "Generative Machine Learning of ADAR Substrates for Precise and Efficient RNA Editing," introduces DeepREAD (Deep learning for RNA Editing by ADAR Design), one of Shape's custom ...

Poseida Therapeutics shows promising early results in myeloma with their BCMA-directed ... An Underappreciated Company Continuing To Shape Up Well In 2024. Sep. 09, 2024 9:16 AM ET Poseida ...

Shape Therapeutics, Inc. - (GLOBE NEWSWIRE) May 16, 2025 May 16, 2025; Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability ...

About Shape Therapeutics . ShapeTX is an AI-driven genomic medicines company focused on creating curative and transformative medicines through its programmable RNA editing technology.

SEATTLE, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today released two preprint manuscripts detailing major technological breakthroughs that underpin ...

Shape Therapeutics introduces advances in AI-powered platform for precision RNA editing: Seattle Saturday, October 5, 2024, 13:00 Hrs [IST] Shape Therapeutics, a leader in RNA-based gene therapy, has ...